ADMA Biologics Inc (ADMA)
6.615
-0.13
(-1.93%)
USD |
NASDAQ |
Mar 28, 12:54
ADMA Biologics Cash and Short Term Investments (Quarterly): 51.35M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 51.35M |
September 30, 2023 | 74.16M |
June 30, 2023 | 62.51M |
March 31, 2023 | 69.20M |
December 31, 2022 | 86.52M |
September 30, 2022 | 34.91M |
June 30, 2022 | 52.42M |
March 31, 2022 | 69.50M |
December 31, 2021 | 51.09M |
September 30, 2021 | 34.41M |
June 30, 2021 | 42.41M |
March 31, 2021 | 61.97M |
December 31, 2020 | 55.92M |
September 30, 2020 | 59.68M |
June 30, 2020 | 75.78M |
March 31, 2020 | 101.24M |
December 31, 2019 | 26.75M |
September 30, 2019 | 48.01M |
June 30, 2019 | 73.62M |
March 31, 2019 | 16.53M |
December 31, 2018 | 22.75M |
September 30, 2018 | 42.37M |
June 30, 2018 | 55.15M |
March 31, 2018 | 26.12M |
December 31, 2017 | 43.11M |
Date | Value |
---|---|
September 30, 2017 | 13.60M |
June 30, 2017 | 25.57M |
March 31, 2017 | 8.788M |
December 31, 2016 | 15.31M |
September 30, 2016 | 18.93M |
June 30, 2016 | 23.82M |
March 31, 2016 | 11.62M |
December 31, 2015 | 16.81M |
September 30, 2015 | 20.94M |
June 30, 2015 | 23.75M |
March 31, 2015 | 28.08M |
December 31, 2014 | 21.85M |
September 30, 2014 | 20.27M |
June 30, 2014 | 24.18M |
March 31, 2014 | 28.72M |
December 31, 2013 | 29.08M |
September 30, 2013 | 5.38M |
June 30, 2013 | 7.654M |
March 31, 2013 | 10.32M |
December 31, 2012 | 12.54M |
September 30, 2012 | 10.72M |
June 30, 2012 | 12.89M |
March 31, 2012 | 14.24M |
December 31, 2011 | 0.0081M |
September 30, 2011 | 0.0059M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
16.53M
Minimum
Mar 2019
101.24M
Maximum
Mar 2020
57.40M
Average
57.80M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Puma Biotechnology Inc | 95.94M |
ANI Pharmaceuticals Inc | 221.12M |
Vanda Pharmaceuticals Inc | 388.26M |
Bristol-Myers Squibb Co | 12.28B |
Pfizer Inc | 12.69B |